Preparing for the storm: mitigating the effect of SARS-CoV-2 induced hypercytokinemia

AB Rowaiye, OA Okpalefe, O Ajiroghene, OA Onuh… - 2020 - 95.179.195.156
With increasing fatalities, the COVID-19 pandemic constitutes a formidable global health
challenge. The causative agent, SARS-CoV-2 constantly tests the efficacy of the immune …

[PDF][PDF] Factors predicting hyperimmune response in COVID-19 patients presenting to the emergency department

SE Atıs, M Uguz - researchgate.net
Aim: The aim of this study is to determine the predictive parameters that can be used in the
early determination of hyperimmune response syndrome in the Emergency Department …

[HTML][HTML] The Safety and Efficacy of the Interleukin-1 Antagonist Anakinra in Severe Cases of COVID-19-A Systematic Review and Meta-analysis.

MKR Somagutta, MKL Pormento, P Hamid, A Hamdan… - 2020 - europepmc.org
This study aims to assess anakinra's safety and efficacy for treating severe coronavirus
disease in 2019 (COVID-19). PubMed, Google Scholar, Cochrane Library, Embase, Scopus …